Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line
- PMID: 1533045
- PMCID: PMC48910
- DOI: 10.1073/pnas.89.8.3571
Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line
Erratum in
- Proc Natl Acad Sci U S A 1992 Sep 1;89(17):8408
Abstract
The synthetic glucocorticoid dexamethasone (1 microM to 1 pM) strongly (maximum greater than 80%) inhibits proliferation of the A549 human lung adenocarcinoma line (EC50 greater than 1 nM) and leads to the appearance, or a further increase (approximately 3-fold) in the expression on the cell surface, of the calcium and phospholipid binding protein lipocortin (annexin) 1. Both these effects, which are shared by hydrocortisone (1 microM) but not by progesterone or aldosterone (1 microM), are inhibited by the antiglucocorticoids RU38486 and RU43044 (1 microM). The nonsteroidal antiinflammatory drugs indomethacin (1 microM) and naproxen (10 microM) and human recombinant lipocortin 1 (0.05-5.0 micrograms/ml) also produce growth arrest in this cell line. During proliferation A549 cells spontaneously release prostaglandin E2 [10-20 ng (28-57 pmol) per ml per 5-day period] into the growth medium. In concentrations that cause growth-arrest, dexamethasone, indomethacin, and lipocortin 1 abolish the generation of this eicosanoid by A549 cells. Prostaglandin E2 itself (0.01-1 pM) stimulates cell growth and partially reverses (approximately 50%) the inhibition of growth caused by dexamethasone and indomethacin. Addition of the neutralizing anti-lipocortin 1 monoclonal antibody 1A (5 micrograms/ml), but not the nonneutralizing anti-lipocortin monoclonal antibody 1B, substantially reversed (greater than 80%) the inhibitory activity of dexamethasone on both growth and prostaglandin E2 synthesis. The generation of prostaglandin E2 by A549 cells seems to be an important regulator of cell proliferation in vitro and the dexamethasone-induced suppression of proliferation in this model is attributable to eicosanoid inhibition caused by lipocortin 1.
Similar articles
-
Lipocortin-I inhibits the synthesis and release of prolactin from human decidual cells: evidence for autocrine/paracrine regulation by lipocortin-I.Endocrinology. 1991 Feb;128(2):1123-8. doi: 10.1210/endo-128-2-1123. Endocrinology. 1991. PMID: 1824932
-
Antisense oligonucleotides to human lipocortin-1 inhibit glucocorticoid-induced inhibition of A549 cell growth and eicosanoid release.Biochem Pharmacol. 1994 Nov 1;48(9):1729-34. doi: 10.1016/0006-2952(94)90458-8. Biochem Pharmacol. 1994. PMID: 7980642
-
Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis.J Biol Chem. 1989 Feb 25;264(6):3506-13. J Biol Chem. 1989. PMID: 2521636
-
Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids.Prog Clin Biol Res. 1990;349:27-45. Prog Clin Biol Res. 1990. PMID: 2144640 Review.
-
[Mechanism of action of glucocorticoids: role of lipocortins].Rev Neurol (Paris). 1989;145(12):813-8. Rev Neurol (Paris). 1989. PMID: 2533385 Review. French.
Cited by
-
Differential modulation of glucocorticoid action by FK506 in A549 cells.Biochem J. 2003 Nov 15;376(Pt 1):285-90. doi: 10.1042/BJ20030821. Biochem J. 2003. PMID: 12948397 Free PMC article.
-
Dexamethasone-induced and estradiol-induced CREB activation and annexin 1 expression in CCRF-CEM lymphoblastic cells: evidence for the involvement of cAMP and p38 MAPK.Mediators Inflamm. 2003 Dec;12(6):329-37. doi: 10.1080/09629350310001633351. Mediators Inflamm. 2003. PMID: 14668092 Free PMC article.
-
Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat.Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3473-7. doi: 10.1073/pnas.92.8.3473. Proc Natl Acad Sci U S A. 1995. PMID: 7536934 Free PMC article.
-
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.World J Gastroenterol. 2013 Nov 28;19(44):7947-54. doi: 10.3748/wjg.v19.i44.7947. World J Gastroenterol. 2013. PMID: 24307788 Free PMC article. Review.
-
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism.Br J Pharmacol. 2000 May;130(2):289-98. doi: 10.1038/sj.bjp.0703272. Br J Pharmacol. 2000. PMID: 10807665 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials